The third quarter Medical device regulatory risk meeting will be held

On October 24, the Department of Device Supervision of the State Food and Drug Administration organized the Medical Device Supervision Risk Conference in the third quarter of 2023.

Verification center, evaluation Center, Nanfang Institute, Acceptance and reporting Center, media group and other units conducted risk consultation and disposal around the medical device flight inspection and overseas inspection, adverse event monitoring, complaint reporting, online sales and public opinion monitoring in the third quarter.

The meeting required that the drug regulatory authorities should continue to strengthen the risk consultation, timely find and effectively dispose of the quality and safety risks of medical devices.

To strengthen the supervision of key products, key enterprises and key areas, ensure that risk detection in the early stage and disposal in the early stage, and effectively ensure the quality and safety of medical devices.

Relevant departments and staff of state Food and Drug Administration will attend the meeting.

Shandong Zhushi Pharmaceutical Group Co., Ltd., founded in 2003, has more than 5000 registered employees. After years of development, it has developed into a diversified industrial cluster integrating medical devices, polymers, cosmetics, health food, daily necessities and biological reagent production, enterprise management consulting and training, real estate economy, pharmaceutical transportation, pharmaceutical printing, etc.

Adhering to the concept of life, health and happiness, the Group provides you with full chain health services.

HOT

NEW